Lv2
140 积分 2023-10-31 加入
Lipid Metabolism and Emerging Targets for Lipid-Lowering Therapy
12天前
已完结
RN026: A lipoprotein(a) targeting siRNA with superior efficacy, extended duration and excellent safety profiles
2个月前
已关闭
Translational and clinical development of therapeutic siRNA and ASOs: current industry practices, perspectives, and recommendations
3个月前
已完结
Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3
3个月前
已完结
Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3
3个月前
已完结
Angiopoietin-Like 3 Antibody Therapy in Patients With Suboptimally Controlled Hyperlipidemia
3个月前
已完结
SHR-1918, A Monoclonal Antibody Against Angiopoietin-Like 3, in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Study
3个月前
已完结
SHR-1918, A Monoclonal Antibody Against Angiopoietin-Like 3, in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Study
3个月前
已完结
The Mysteries Of Lipoprotein(a)
3个月前
已完结
RNAi-mediated knockdown of HMG CoA reductase enhances gene expression from physiologically regulated low-density lipoprotein receptor therapeutic vectors in vivo
4个月前
已完结
皖公网安备34019202002308
